Al. Zignego et al., INAPPARENT HEPATITIS-B VIRUS-INFECTION AND HEPATITIS-C VIRUS-REPLICATION IN ALCOHOLIC SUBJECTS WITH AND WITHOUT LIVER-DISEASE, Hepatology, 19(3), 1994, pp. 577-582
We evaluated hepatitis B virus DNA and hepatitis C virus RNA in sera f
rom 110 HBsAg and IgM HBc antibody-negative heavy drinkers (50 cirrhos
is, 13 chronic active hepatitis, 25 fatty liver with or without mild t
o moderate fibrosis, alcoholic hepatitis or both and 22 healthy alcoho
lic subjects) with polymerase chain reaction. Results of hepatitis C v
irus polymerase chain reaction were compared with those obtained with
two tests (second generation recombinant immunoblot assay and enzyme-l
inked immunosorbent assay) used to detect hepatitis C virus antibodies
. Hepatitis B virus DNA was found in three (2.7%) patients. Hepatitis
C virus RNA was detected in 29 (29.8%) of the 97 subjects whose sera w
ere well preserved for RNA extraction (42.5% cirrhosis, 83.3% chronic
active hepatitis, 8% fatty liver and 0% healthy alcoholic subjects). R
esults obtained with second-generation recombinant immunoblot assay an
d enzyme-linked immunosorbent assay had a high degree of agreement wit
h polymerase chain reaction as expected, the kappa indexes being 0.76
and 0.61, respectively. Nevertheless, five hepatitis C virus RNA-posit
ive patients had negative recombinant immunoblot assay results, wherea
s all hepatitis C virus RNA-positive patients had positive or borderli
ne enzyme-linked immunosorbent assay results. We conclude that, in Ita
lian HBsAg-negative alcoholic patients, ''inapparent'' hepatitis B vir
us infection is rare. On the contrary, hepatitis C virus infection, as
detected on hepatitis C virus polymerase chain reaction, is quite fre
quent, especially in patients who have cirrhosis and chronic active he
patitis. Second-generation enzyme-linked immunosorbent assay can be re
liably used as initial test for the detection of hepatitis C virus inf
ection in alcoholic patients; clearly positive results are very likely
to correspond to viremia. Borderline results necessitate confirmation
with polymerase chain reaction analysis.